Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England

PURPOSE: Selection of treatments for patients with chronic obstructive pulmonary disease (COPD) may impact clinical outcomes, healthcare resource use (HCRU) and direct healthcare costs. We aimed to characterize these outcomes along with treatment patterns, for patients with COPD following initiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Requena, Gema, Banks, Victoria, Czira, Alexandrosz, Wood, Robert, Tritton, Theo, Wild, Rosie, Compton, Chris, Ismaila, Afisi S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997204/
https://www.ncbi.nlm.nih.gov/pubmed/36908830
http://dx.doi.org/10.2147/COPD.S389281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997204/
https://www.ncbi.nlm.nih.gov/pubmed/36908830
http://dx.doi.org/10.2147/COPD.S389281

Ejemplares similares